nodes	percent_of_prediction	percent_of_DWPC	metapath
Zileuton—EPHX2—Fulvestrant—breast cancer	0.336	0.648	CbGbCtD
Zileuton—PTGS1—breast cancer	0.156	0.631	CbGaD
Zileuton—CYP3A4—breast cancer	0.0909	0.369	CbGaD
Zileuton—UGT1A9—Irinotecan—breast cancer	0.0214	0.0412	CbGbCtD
Zileuton—CYP1A2—Anastrozole—breast cancer	0.0155	0.0298	CbGbCtD
Zileuton—CYP1A2—Toremifene—breast cancer	0.0141	0.0273	CbGbCtD
Zileuton—CYP2C9—Anastrozole—breast cancer	0.0139	0.0269	CbGbCtD
Zileuton—CYP3A4—Exemestane—breast cancer	0.0107	0.0206	CbGbCtD
Zileuton—CYP2C9—Idarubicin—breast cancer	0.0106	0.0204	CbGbCtD
Zileuton—CYP3A4—Letrozole—breast cancer	0.00909	0.0175	CbGbCtD
Zileuton—CYP3A4—Anastrozole—breast cancer	0.0081	0.0156	CbGbCtD
Zileuton—CYP3A4—Toremifene—breast cancer	0.00741	0.0143	CbGbCtD
Zileuton—CYP3A4—Fulvestrant—breast cancer	0.00689	0.0133	CbGbCtD
Zileuton—CYP3A4—Thiotepa—breast cancer	0.00614	0.0118	CbGbCtD
Zileuton—CYP2C9—Capecitabine—breast cancer	0.00578	0.0112	CbGbCtD
Zileuton—CYP3A4—Ixabepilone—breast cancer	0.00561	0.0108	CbGbCtD
Zileuton—CYP3A4—Lapatinib—breast cancer	0.0054	0.0104	CbGbCtD
Zileuton—CYP1A2—Tamoxifen—breast cancer	0.00516	0.00996	CbGbCtD
Zileuton—CYP2C9—Tamoxifen—breast cancer	0.00465	0.00898	CbGbCtD
Zileuton—CYP3A4—Raloxifene—breast cancer	0.00409	0.0079	CbGbCtD
Zileuton—CYP1A2—Fluorouracil—breast cancer	0.00381	0.00734	CbGbCtD
Zileuton—CYP2C9—Paclitaxel—breast cancer	0.00362	0.00699	CbGbCtD
Zileuton—CYP2C9—Fluorouracil—breast cancer	0.00343	0.00661	CbGbCtD
Zileuton—CYP3A4—Vinorelbine—breast cancer	0.003	0.00578	CbGbCtD
Zileuton—LTB4R—nipple—breast cancer	0.00293	0.0863	CbGeAlD
Zileuton—CYP3A4—Tamoxifen—breast cancer	0.00271	0.00522	CbGbCtD
Zileuton—CYP3A4—Mitoxantrone—breast cancer	0.00264	0.00509	CbGbCtD
Zileuton—EPHX2—mammary gland—breast cancer	0.00261	0.0768	CbGeAlD
Zileuton—CYP3A4—Paclitaxel—breast cancer	0.00211	0.00406	CbGbCtD
Zileuton—CYP3A4—Irinotecan—breast cancer	0.00208	0.00401	CbGbCtD
Zileuton—LTB4R—skin of body—breast cancer	0.00188	0.0553	CbGeAlD
Zileuton—CYP3A4—Vinblastine—breast cancer	0.00185	0.00356	CbGbCtD
Zileuton—LTB4R—pituitary gland—breast cancer	0.0016	0.0472	CbGeAlD
Zileuton—LTB4R—adipose tissue—breast cancer	0.0016	0.047	CbGeAlD
Zileuton—CYP3A4—Docetaxel—breast cancer	0.00152	0.00294	CbGbCtD
Zileuton—LTB4R—adrenal gland—breast cancer	0.00143	0.0421	CbGeAlD
Zileuton—LTB4R—bone marrow—breast cancer	0.00138	0.0408	CbGeAlD
Zileuton—LTB4R—female gonad—breast cancer	0.00133	0.0393	CbGeAlD
Zileuton—LTB4R—endocrine gland—breast cancer	0.00124	0.0365	CbGeAlD
Zileuton—EPHX2—uterus—breast cancer	0.0012	0.0353	CbGeAlD
Zileuton—EPHX2—pituitary gland—breast cancer	0.00118	0.0347	CbGeAlD
Zileuton—EPHX2—adipose tissue—breast cancer	0.00117	0.0346	CbGeAlD
Zileuton—CYP3A4—Doxorubicin—breast cancer	0.00113	0.00219	CbGbCtD
Zileuton—EPHX2—adrenal gland—breast cancer	0.00105	0.031	CbGeAlD
Zileuton—EPHX2—female gonad—breast cancer	0.000982	0.0289	CbGeAlD
Zileuton—LTB4R—lymph node—breast cancer	0.000858	0.0253	CbGeAlD
Zileuton—UGT1A9—endocrine gland—breast cancer	0.000835	0.0246	CbGeAlD
Zileuton—ALOX5—adipose tissue—breast cancer	0.000703	0.0207	CbGeAlD
Zileuton—CYP2C9—mammary gland—breast cancer	0.000687	0.0202	CbGeAlD
Zileuton—ALOX5—female reproductive system—breast cancer	0.000647	0.019	CbGeAlD
Zileuton—EPHX2—lymph node—breast cancer	0.000631	0.0186	CbGeAlD
Zileuton—ALOX5—adrenal gland—breast cancer	0.000631	0.0186	CbGeAlD
Zileuton—ALOX5—bone marrow—breast cancer	0.00061	0.018	CbGeAlD
Zileuton—CYP1A2—nipple—breast cancer	0.000599	0.0176	CbGeAlD
Zileuton—ALOX5—female gonad—breast cancer	0.000588	0.0173	CbGeAlD
Zileuton—ALOX5—endocrine gland—breast cancer	0.000547	0.0161	CbGeAlD
Zileuton—Tiaprofenic acid—PTGS1—breast cancer	0.000531	0.636	CrCbGaD
Zileuton—PTGS1—nipple—breast cancer	0.000519	0.0153	CbGeAlD
Zileuton—ALOX5—lymph node—breast cancer	0.000378	0.0111	CbGeAlD
Zileuton—PTGS1—epithelium—breast cancer	0.000349	0.0103	CbGeAlD
Zileuton—PTGS1—skin of body—breast cancer	0.000332	0.00978	CbGeAlD
Zileuton—PTGS1—endometrium—breast cancer	0.000313	0.00922	CbGeAlD
Zileuton—Tiaprofenic acid—PTGS2—breast cancer	0.000304	0.364	CrCbGaD
Zileuton—PTGS1—uterus—breast cancer	0.000289	0.0085	CbGeAlD
Zileuton—CYP2C9—female reproductive system—breast cancer	0.000284	0.00837	CbGeAlD
Zileuton—PTGS1—pituitary gland—breast cancer	0.000283	0.00834	CbGeAlD
Zileuton—PTGS1—adipose tissue—breast cancer	0.000282	0.00831	CbGeAlD
Zileuton—PTGS1—female reproductive system—breast cancer	0.00026	0.00764	CbGeAlD
Zileuton—CYP1A2—endocrine gland—breast cancer	0.000253	0.00746	CbGeAlD
Zileuton—PTGS1—adrenal gland—breast cancer	0.000253	0.00745	CbGeAlD
Zileuton—CYP2C9—endocrine gland—breast cancer	0.000241	0.00708	CbGeAlD
Zileuton—PTGS1—female gonad—breast cancer	0.000236	0.00695	CbGeAlD
Zileuton—PTGS1—endocrine gland—breast cancer	0.00022	0.00646	CbGeAlD
Zileuton—CYP3A4—female reproductive system—breast cancer	0.000217	0.00638	CbGeAlD
Zileuton—CYP3A4—endocrine gland—breast cancer	0.000183	0.0054	CbGeAlD
Zileuton—PTGS1—lymph node—breast cancer	0.000152	0.00447	CbGeAlD
Zileuton—Dyspepsia—Mitoxantrone—breast cancer	9.5e-05	0.000881	CcSEcCtD
Zileuton—Rash—Melphalan—breast cancer	9.45e-05	0.000876	CcSEcCtD
Zileuton—Dermatitis—Melphalan—breast cancer	9.44e-05	0.000875	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Fluorouracil—breast cancer	9.42e-05	0.000873	CcSEcCtD
Zileuton—Nausea—Vinblastine—breast cancer	9.36e-05	0.000867	CcSEcCtD
Zileuton—Abdominal pain upper—Epirubicin—breast cancer	9.36e-05	0.000867	CcSEcCtD
Zileuton—Insomnia—Fluorouracil—breast cancer	9.35e-05	0.000867	CcSEcCtD
Zileuton—Somnolence—Gemcitabine—breast cancer	9.35e-05	0.000866	CcSEcCtD
Zileuton—Gastrointestinal disorder—Irinotecan—breast cancer	9.32e-05	0.000864	CcSEcCtD
Zileuton—Vomiting—Goserelin—breast cancer	9.29e-05	0.000861	CcSEcCtD
Zileuton—Pruritus—Vinorelbine—breast cancer	9.26e-05	0.000858	CcSEcCtD
Zileuton—Pain—Mitoxantrone—breast cancer	9.23e-05	0.000856	CcSEcCtD
Zileuton—Constipation—Mitoxantrone—breast cancer	9.23e-05	0.000856	CcSEcCtD
Zileuton—Pain—Irinotecan—breast cancer	9.23e-05	0.000856	CcSEcCtD
Zileuton—Constipation—Irinotecan—breast cancer	9.23e-05	0.000856	CcSEcCtD
Zileuton—Rash—Goserelin—breast cancer	9.22e-05	0.000854	CcSEcCtD
Zileuton—Hypersensitivity—Thiotepa—breast cancer	9.21e-05	0.000854	CcSEcCtD
Zileuton—Dermatitis—Goserelin—breast cancer	9.21e-05	0.000853	CcSEcCtD
Zileuton—Somnolence—Fluorouracil—breast cancer	9.19e-05	0.000852	CcSEcCtD
Zileuton—Arthralgia—Paclitaxel—breast cancer	9.19e-05	0.000851	CcSEcCtD
Zileuton—Chest pain—Paclitaxel—breast cancer	9.19e-05	0.000851	CcSEcCtD
Zileuton—Myalgia—Paclitaxel—breast cancer	9.19e-05	0.000851	CcSEcCtD
Zileuton—Headache—Goserelin—breast cancer	9.16e-05	0.000849	CcSEcCtD
Zileuton—Dyspepsia—Fluorouracil—breast cancer	9.1e-05	0.000844	CcSEcCtD
Zileuton—Nausea—Tamoxifen—breast cancer	9.09e-05	0.000842	CcSEcCtD
Zileuton—Gastrointestinal disorder—Gemcitabine—breast cancer	9.08e-05	0.000841	CcSEcCtD
Zileuton—Discomfort—Paclitaxel—breast cancer	9.08e-05	0.000841	CcSEcCtD
Zileuton—Pain—Gemcitabine—breast cancer	8.99e-05	0.000833	CcSEcCtD
Zileuton—Constipation—Gemcitabine—breast cancer	8.99e-05	0.000833	CcSEcCtD
Zileuton—Diarrhoea—Vinorelbine—breast cancer	8.96e-05	0.00083	CcSEcCtD
Zileuton—Gastrointestinal disorder—Fluorouracil—breast cancer	8.93e-05	0.000827	CcSEcCtD
Zileuton—Nausea—Melphalan—breast cancer	8.9e-05	0.000825	CcSEcCtD
Zileuton—Feeling abnormal—Irinotecan—breast cancer	8.9e-05	0.000824	CcSEcCtD
Zileuton—Feeling abnormal—Mitoxantrone—breast cancer	8.9e-05	0.000824	CcSEcCtD
Zileuton—Pruritus—Thiotepa—breast cancer	8.85e-05	0.00082	CcSEcCtD
Zileuton—Pain—Fluorouracil—breast cancer	8.84e-05	0.000819	CcSEcCtD
Zileuton—Upper respiratory tract infection—Methotrexate—breast cancer	8.79e-05	0.000815	CcSEcCtD
Zileuton—Flatulence—Capecitabine—breast cancer	8.73e-05	0.000808	CcSEcCtD
Zileuton—Nausea—Goserelin—breast cancer	8.68e-05	0.000805	CcSEcCtD
Zileuton—Feeling abnormal—Gemcitabine—breast cancer	8.67e-05	0.000803	CcSEcCtD
Zileuton—Dizziness—Vinorelbine—breast cancer	8.66e-05	0.000802	CcSEcCtD
Zileuton—Abdominal pain upper—Doxorubicin—breast cancer	8.66e-05	0.000802	CcSEcCtD
Zileuton—Urticaria—Mitoxantrone—breast cancer	8.58e-05	0.000795	CcSEcCtD
Zileuton—Diarrhoea—Thiotepa—breast cancer	8.55e-05	0.000793	CcSEcCtD
Zileuton—Body temperature increased—Mitoxantrone—breast cancer	8.54e-05	0.000791	CcSEcCtD
Zileuton—Body temperature increased—Irinotecan—breast cancer	8.54e-05	0.000791	CcSEcCtD
Zileuton—Feeling abnormal—Fluorouracil—breast cancer	8.52e-05	0.00079	CcSEcCtD
Zileuton—Vomiting—Vinorelbine—breast cancer	8.32e-05	0.000771	CcSEcCtD
Zileuton—Body temperature increased—Gemcitabine—breast cancer	8.31e-05	0.00077	CcSEcCtD
Zileuton—Dizziness—Thiotepa—breast cancer	8.27e-05	0.000766	CcSEcCtD
Zileuton—Rash—Vinorelbine—breast cancer	8.25e-05	0.000765	CcSEcCtD
Zileuton—Dermatitis—Vinorelbine—breast cancer	8.25e-05	0.000764	CcSEcCtD
Zileuton—Upper respiratory tract infection—Epirubicin—breast cancer	8.23e-05	0.000762	CcSEcCtD
Zileuton—Ill-defined disorder—Capecitabine—breast cancer	8.22e-05	0.000761	CcSEcCtD
Zileuton—Urticaria—Fluorouracil—breast cancer	8.22e-05	0.000761	CcSEcCtD
Zileuton—Headache—Vinorelbine—breast cancer	8.2e-05	0.00076	CcSEcCtD
Zileuton—Conjunctivitis—Methotrexate—breast cancer	8.2e-05	0.00076	CcSEcCtD
Zileuton—Body temperature increased—Fluorouracil—breast cancer	8.18e-05	0.000758	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Paclitaxel—breast cancer	8.02e-05	0.000743	CcSEcCtD
Zileuton—Malaise—Capecitabine—breast cancer	7.99e-05	0.00074	CcSEcCtD
Zileuton—Insomnia—Paclitaxel—breast cancer	7.96e-05	0.000738	CcSEcCtD
Zileuton—Hypersensitivity—Mitoxantrone—breast cancer	7.96e-05	0.000737	CcSEcCtD
Zileuton—Hypersensitivity—Irinotecan—breast cancer	7.96e-05	0.000737	CcSEcCtD
Zileuton—Vomiting—Thiotepa—breast cancer	7.95e-05	0.000737	CcSEcCtD
Zileuton—Rash—Thiotepa—breast cancer	7.88e-05	0.00073	CcSEcCtD
Zileuton—Dermatitis—Thiotepa—breast cancer	7.88e-05	0.00073	CcSEcCtD
Zileuton—Headache—Thiotepa—breast cancer	7.83e-05	0.000726	CcSEcCtD
Zileuton—Somnolence—Paclitaxel—breast cancer	7.83e-05	0.000725	CcSEcCtD
Zileuton—Arthralgia—Docetaxel—breast cancer	7.79e-05	0.000721	CcSEcCtD
Zileuton—Chest pain—Docetaxel—breast cancer	7.79e-05	0.000721	CcSEcCtD
Zileuton—Myalgia—Docetaxel—breast cancer	7.79e-05	0.000721	CcSEcCtD
Zileuton—Nausea—Vinorelbine—breast cancer	7.78e-05	0.000721	CcSEcCtD
Zileuton—Dyspepsia—Paclitaxel—breast cancer	7.75e-05	0.000718	CcSEcCtD
Zileuton—Jaundice—Epirubicin—breast cancer	7.69e-05	0.000713	CcSEcCtD
Zileuton—Urinary tract infection—Epirubicin—breast cancer	7.67e-05	0.000711	CcSEcCtD
Zileuton—Conjunctivitis—Epirubicin—breast cancer	7.67e-05	0.000711	CcSEcCtD
Zileuton—Hypersensitivity—Fluorouracil—breast cancer	7.62e-05	0.000706	CcSEcCtD
Zileuton—Upper respiratory tract infection—Doxorubicin—breast cancer	7.61e-05	0.000705	CcSEcCtD
Zileuton—Gastrointestinal disorder—Paclitaxel—breast cancer	7.6e-05	0.000704	CcSEcCtD
Zileuton—Hepatitis—Methotrexate—breast cancer	7.57e-05	0.000702	CcSEcCtD
Zileuton—Arthralgia—Capecitabine—breast cancer	7.54e-05	0.000699	CcSEcCtD
Zileuton—Myalgia—Capecitabine—breast cancer	7.54e-05	0.000699	CcSEcCtD
Zileuton—Chest pain—Capecitabine—breast cancer	7.54e-05	0.000699	CcSEcCtD
Zileuton—Pain—Paclitaxel—breast cancer	7.53e-05	0.000698	CcSEcCtD
Zileuton—Constipation—Paclitaxel—breast cancer	7.53e-05	0.000698	CcSEcCtD
Zileuton—Discomfort—Capecitabine—breast cancer	7.45e-05	0.00069	CcSEcCtD
Zileuton—Pruritus—Gemcitabine—breast cancer	7.44e-05	0.00069	CcSEcCtD
Zileuton—Nausea—Thiotepa—breast cancer	7.43e-05	0.000688	CcSEcCtD
Zileuton—Sinusitis—Epirubicin—breast cancer	7.41e-05	0.000686	CcSEcCtD
Zileuton—Diarrhoea—Irinotecan—breast cancer	7.39e-05	0.000685	CcSEcCtD
Zileuton—Diarrhoea—Mitoxantrone—breast cancer	7.39e-05	0.000685	CcSEcCtD
Zileuton—Pruritus—Fluorouracil—breast cancer	7.32e-05	0.000678	CcSEcCtD
Zileuton—Feeling abnormal—Paclitaxel—breast cancer	7.26e-05	0.000672	CcSEcCtD
Zileuton—Diarrhoea—Gemcitabine—breast cancer	7.2e-05	0.000667	CcSEcCtD
Zileuton—Dizziness—Irinotecan—breast cancer	7.14e-05	0.000662	CcSEcCtD
Zileuton—Jaundice—Doxorubicin—breast cancer	7.12e-05	0.00066	CcSEcCtD
Zileuton—Conjunctivitis—Doxorubicin—breast cancer	7.1e-05	0.000658	CcSEcCtD
Zileuton—Urinary tract infection—Doxorubicin—breast cancer	7.1e-05	0.000658	CcSEcCtD
Zileuton—Hepatitis—Epirubicin—breast cancer	7.09e-05	0.000657	CcSEcCtD
Zileuton—Diarrhoea—Fluorouracil—breast cancer	7.08e-05	0.000656	CcSEcCtD
Zileuton—Urticaria—Paclitaxel—breast cancer	7e-05	0.000648	CcSEcCtD
Zileuton—Body temperature increased—Paclitaxel—breast cancer	6.96e-05	0.000645	CcSEcCtD
Zileuton—Vomiting—Irinotecan—breast cancer	6.87e-05	0.000636	CcSEcCtD
Zileuton—Vomiting—Mitoxantrone—breast cancer	6.87e-05	0.000636	CcSEcCtD
Zileuton—Sinusitis—Doxorubicin—breast cancer	6.85e-05	0.000635	CcSEcCtD
Zileuton—Dizziness—Fluorouracil—breast cancer	6.84e-05	0.000634	CcSEcCtD
Zileuton—Rash—Mitoxantrone—breast cancer	6.81e-05	0.000631	CcSEcCtD
Zileuton—Rash—Irinotecan—breast cancer	6.81e-05	0.000631	CcSEcCtD
Zileuton—Dermatitis—Irinotecan—breast cancer	6.8e-05	0.00063	CcSEcCtD
Zileuton—Dermatitis—Mitoxantrone—breast cancer	6.8e-05	0.00063	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Docetaxel—breast cancer	6.8e-05	0.00063	CcSEcCtD
Zileuton—Headache—Mitoxantrone—breast cancer	6.76e-05	0.000627	CcSEcCtD
Zileuton—Headache—Irinotecan—breast cancer	6.76e-05	0.000627	CcSEcCtD
Zileuton—Insomnia—Docetaxel—breast cancer	6.75e-05	0.000626	CcSEcCtD
Zileuton—Vomiting—Gemcitabine—breast cancer	6.69e-05	0.00062	CcSEcCtD
Zileuton—Somnolence—Docetaxel—breast cancer	6.64e-05	0.000615	CcSEcCtD
Zileuton—Rash—Gemcitabine—breast cancer	6.63e-05	0.000615	CcSEcCtD
Zileuton—Dermatitis—Gemcitabine—breast cancer	6.63e-05	0.000614	CcSEcCtD
Zileuton—Headache—Gemcitabine—breast cancer	6.59e-05	0.000611	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Capecitabine—breast cancer	6.58e-05	0.00061	CcSEcCtD
Zileuton—Vomiting—Fluorouracil—breast cancer	6.58e-05	0.000609	CcSEcCtD
Zileuton—Dyspepsia—Docetaxel—breast cancer	6.57e-05	0.000609	CcSEcCtD
Zileuton—Hepatitis—Doxorubicin—breast cancer	6.56e-05	0.000608	CcSEcCtD
Zileuton—Insomnia—Capecitabine—breast cancer	6.54e-05	0.000606	CcSEcCtD
Zileuton—Rash—Fluorouracil—breast cancer	6.52e-05	0.000604	CcSEcCtD
Zileuton—Dermatitis—Fluorouracil—breast cancer	6.51e-05	0.000604	CcSEcCtD
Zileuton—Hypersensitivity—Paclitaxel—breast cancer	6.49e-05	0.000601	CcSEcCtD
Zileuton—Headache—Fluorouracil—breast cancer	6.48e-05	0.0006	CcSEcCtD
Zileuton—Gastrointestinal disorder—Docetaxel—breast cancer	6.44e-05	0.000597	CcSEcCtD
Zileuton—Nausea—Mitoxantrone—breast cancer	6.41e-05	0.000594	CcSEcCtD
Zileuton—Nausea—Irinotecan—breast cancer	6.41e-05	0.000594	CcSEcCtD
Zileuton—Pain—Docetaxel—breast cancer	6.38e-05	0.000591	CcSEcCtD
Zileuton—Constipation—Docetaxel—breast cancer	6.38e-05	0.000591	CcSEcCtD
Zileuton—Dyspepsia—Capecitabine—breast cancer	6.36e-05	0.000589	CcSEcCtD
Zileuton—Nausea—Gemcitabine—breast cancer	6.25e-05	0.000579	CcSEcCtD
Zileuton—Gastrointestinal disorder—Capecitabine—breast cancer	6.24e-05	0.000578	CcSEcCtD
Zileuton—Pruritus—Paclitaxel—breast cancer	6.23e-05	0.000577	CcSEcCtD
Zileuton—Pain—Capecitabine—breast cancer	6.18e-05	0.000573	CcSEcCtD
Zileuton—Constipation—Capecitabine—breast cancer	6.18e-05	0.000573	CcSEcCtD
Zileuton—Feeling abnormal—Docetaxel—breast cancer	6.15e-05	0.00057	CcSEcCtD
Zileuton—Nausea—Fluorouracil—breast cancer	6.14e-05	0.000569	CcSEcCtD
Zileuton—Ill-defined disorder—Methotrexate—breast cancer	6.12e-05	0.000567	CcSEcCtD
Zileuton—Flatulence—Epirubicin—breast cancer	6.08e-05	0.000563	CcSEcCtD
Zileuton—Tension—Epirubicin—breast cancer	6.05e-05	0.000561	CcSEcCtD
Zileuton—Diarrhoea—Paclitaxel—breast cancer	6.03e-05	0.000558	CcSEcCtD
Zileuton—Nervousness—Epirubicin—breast cancer	5.99e-05	0.000555	CcSEcCtD
Zileuton—Feeling abnormal—Capecitabine—breast cancer	5.96e-05	0.000552	CcSEcCtD
Zileuton—Malaise—Methotrexate—breast cancer	5.94e-05	0.000551	CcSEcCtD
Zileuton—Body temperature increased—Docetaxel—breast cancer	5.9e-05	0.000547	CcSEcCtD
Zileuton—Dizziness—Paclitaxel—breast cancer	5.82e-05	0.00054	CcSEcCtD
Zileuton—Urticaria—Capecitabine—breast cancer	5.74e-05	0.000532	CcSEcCtD
Zileuton—Ill-defined disorder—Epirubicin—breast cancer	5.72e-05	0.00053	CcSEcCtD
Zileuton—Body temperature increased—Capecitabine—breast cancer	5.71e-05	0.000529	CcSEcCtD
Zileuton—Flatulence—Doxorubicin—breast cancer	5.62e-05	0.000521	CcSEcCtD
Zileuton—Chest pain—Methotrexate—breast cancer	5.61e-05	0.00052	CcSEcCtD
Zileuton—Arthralgia—Methotrexate—breast cancer	5.61e-05	0.00052	CcSEcCtD
Zileuton—Myalgia—Methotrexate—breast cancer	5.61e-05	0.00052	CcSEcCtD
Zileuton—Tension—Doxorubicin—breast cancer	5.6e-05	0.000519	CcSEcCtD
Zileuton—Vomiting—Paclitaxel—breast cancer	5.6e-05	0.000519	CcSEcCtD
Zileuton—Malaise—Epirubicin—breast cancer	5.56e-05	0.000515	CcSEcCtD
Zileuton—Rash—Paclitaxel—breast cancer	5.55e-05	0.000514	CcSEcCtD
Zileuton—Dermatitis—Paclitaxel—breast cancer	5.55e-05	0.000514	CcSEcCtD
Zileuton—Discomfort—Methotrexate—breast cancer	5.54e-05	0.000514	CcSEcCtD
Zileuton—Nervousness—Doxorubicin—breast cancer	5.54e-05	0.000514	CcSEcCtD
Zileuton—Headache—Paclitaxel—breast cancer	5.52e-05	0.000511	CcSEcCtD
Zileuton—Hypersensitivity—Docetaxel—breast cancer	5.5e-05	0.00051	CcSEcCtD
Zileuton—Hypersensitivity—Capecitabine—breast cancer	5.32e-05	0.000493	CcSEcCtD
Zileuton—Ill-defined disorder—Doxorubicin—breast cancer	5.3e-05	0.000491	CcSEcCtD
Zileuton—Pruritus—Docetaxel—breast cancer	5.28e-05	0.000489	CcSEcCtD
Zileuton—Myalgia—Epirubicin—breast cancer	5.25e-05	0.000487	CcSEcCtD
Zileuton—Chest pain—Epirubicin—breast cancer	5.25e-05	0.000487	CcSEcCtD
Zileuton—Arthralgia—Epirubicin—breast cancer	5.25e-05	0.000487	CcSEcCtD
Zileuton—Nausea—Paclitaxel—breast cancer	5.23e-05	0.000485	CcSEcCtD
Zileuton—Discomfort—Epirubicin—breast cancer	5.19e-05	0.000481	CcSEcCtD
Zileuton—Malaise—Doxorubicin—breast cancer	5.15e-05	0.000477	CcSEcCtD
Zileuton—Pruritus—Capecitabine—breast cancer	5.11e-05	0.000474	CcSEcCtD
Zileuton—Diarrhoea—Docetaxel—breast cancer	5.11e-05	0.000473	CcSEcCtD
Zileuton—Diarrhoea—Capecitabine—breast cancer	4.94e-05	0.000458	CcSEcCtD
Zileuton—Dizziness—Docetaxel—breast cancer	4.94e-05	0.000457	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Methotrexate—breast cancer	4.9e-05	0.000454	CcSEcCtD
Zileuton—Insomnia—Methotrexate—breast cancer	4.87e-05	0.000451	CcSEcCtD
Zileuton—Arthralgia—Doxorubicin—breast cancer	4.86e-05	0.00045	CcSEcCtD
Zileuton—Myalgia—Doxorubicin—breast cancer	4.86e-05	0.00045	CcSEcCtD
Zileuton—Chest pain—Doxorubicin—breast cancer	4.86e-05	0.00045	CcSEcCtD
Zileuton—Discomfort—Doxorubicin—breast cancer	4.8e-05	0.000445	CcSEcCtD
Zileuton—Somnolence—Methotrexate—breast cancer	4.78e-05	0.000443	CcSEcCtD
Zileuton—Dizziness—Capecitabine—breast cancer	4.78e-05	0.000443	CcSEcCtD
Zileuton—Vomiting—Docetaxel—breast cancer	4.75e-05	0.00044	CcSEcCtD
Zileuton—Dyspepsia—Methotrexate—breast cancer	4.74e-05	0.000439	CcSEcCtD
Zileuton—Rash—Docetaxel—breast cancer	4.71e-05	0.000436	CcSEcCtD
Zileuton—Dermatitis—Docetaxel—breast cancer	4.7e-05	0.000436	CcSEcCtD
Zileuton—Headache—Docetaxel—breast cancer	4.68e-05	0.000433	CcSEcCtD
Zileuton—Gastrointestinal disorder—Methotrexate—breast cancer	4.64e-05	0.00043	CcSEcCtD
Zileuton—Pain—Methotrexate—breast cancer	4.6e-05	0.000426	CcSEcCtD
Zileuton—Vomiting—Capecitabine—breast cancer	4.59e-05	0.000426	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Epirubicin—breast cancer	4.59e-05	0.000425	CcSEcCtD
Zileuton—Rash—Capecitabine—breast cancer	4.56e-05	0.000422	CcSEcCtD
Zileuton—Insomnia—Epirubicin—breast cancer	4.55e-05	0.000422	CcSEcCtD
Zileuton—Dermatitis—Capecitabine—breast cancer	4.55e-05	0.000422	CcSEcCtD
Zileuton—Headache—Capecitabine—breast cancer	4.53e-05	0.000419	CcSEcCtD
Zileuton—Somnolence—Epirubicin—breast cancer	4.48e-05	0.000415	CcSEcCtD
Zileuton—Nausea—Docetaxel—breast cancer	4.43e-05	0.000411	CcSEcCtD
Zileuton—Feeling abnormal—Methotrexate—breast cancer	4.43e-05	0.000411	CcSEcCtD
Zileuton—Dyspepsia—Epirubicin—breast cancer	4.43e-05	0.000411	CcSEcCtD
Zileuton—Gastrointestinal disorder—Epirubicin—breast cancer	4.35e-05	0.000403	CcSEcCtD
Zileuton—Constipation—Epirubicin—breast cancer	4.31e-05	0.000399	CcSEcCtD
Zileuton—Pain—Epirubicin—breast cancer	4.31e-05	0.000399	CcSEcCtD
Zileuton—Nausea—Capecitabine—breast cancer	4.29e-05	0.000398	CcSEcCtD
Zileuton—Urticaria—Methotrexate—breast cancer	4.27e-05	0.000396	CcSEcCtD
Zileuton—Body temperature increased—Methotrexate—breast cancer	4.25e-05	0.000394	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Doxorubicin—breast cancer	4.24e-05	0.000393	CcSEcCtD
Zileuton—Insomnia—Doxorubicin—breast cancer	4.21e-05	0.00039	CcSEcCtD
Zileuton—Feeling abnormal—Epirubicin—breast cancer	4.15e-05	0.000384	CcSEcCtD
Zileuton—Somnolence—Doxorubicin—breast cancer	4.14e-05	0.000384	CcSEcCtD
Zileuton—Dyspepsia—Doxorubicin—breast cancer	4.1e-05	0.00038	CcSEcCtD
Zileuton—Gastrointestinal disorder—Doxorubicin—breast cancer	4.02e-05	0.000373	CcSEcCtD
Zileuton—Urticaria—Epirubicin—breast cancer	4e-05	0.000371	CcSEcCtD
Zileuton—Pain—Doxorubicin—breast cancer	3.98e-05	0.000369	CcSEcCtD
Zileuton—Constipation—Doxorubicin—breast cancer	3.98e-05	0.000369	CcSEcCtD
Zileuton—Body temperature increased—Epirubicin—breast cancer	3.98e-05	0.000369	CcSEcCtD
Zileuton—Hypersensitivity—Methotrexate—breast cancer	3.96e-05	0.000367	CcSEcCtD
Zileuton—Feeling abnormal—Doxorubicin—breast cancer	3.84e-05	0.000356	CcSEcCtD
Zileuton—Pruritus—Methotrexate—breast cancer	3.81e-05	0.000353	CcSEcCtD
Zileuton—Hypersensitivity—Epirubicin—breast cancer	3.71e-05	0.000344	CcSEcCtD
Zileuton—Urticaria—Doxorubicin—breast cancer	3.7e-05	0.000343	CcSEcCtD
Zileuton—Body temperature increased—Doxorubicin—breast cancer	3.68e-05	0.000341	CcSEcCtD
Zileuton—Diarrhoea—Methotrexate—breast cancer	3.68e-05	0.000341	CcSEcCtD
Zileuton—Pruritus—Epirubicin—breast cancer	3.56e-05	0.00033	CcSEcCtD
Zileuton—Dizziness—Methotrexate—breast cancer	3.56e-05	0.00033	CcSEcCtD
Zileuton—Diarrhoea—Epirubicin—breast cancer	3.44e-05	0.000319	CcSEcCtD
Zileuton—Hypersensitivity—Doxorubicin—breast cancer	3.43e-05	0.000318	CcSEcCtD
Zileuton—Vomiting—Methotrexate—breast cancer	3.42e-05	0.000317	CcSEcCtD
Zileuton—Rash—Methotrexate—breast cancer	3.39e-05	0.000314	CcSEcCtD
Zileuton—Dermatitis—Methotrexate—breast cancer	3.39e-05	0.000314	CcSEcCtD
Zileuton—Headache—Methotrexate—breast cancer	3.37e-05	0.000312	CcSEcCtD
Zileuton—Dizziness—Epirubicin—breast cancer	3.33e-05	0.000308	CcSEcCtD
Zileuton—Pruritus—Doxorubicin—breast cancer	3.3e-05	0.000305	CcSEcCtD
Zileuton—Vomiting—Epirubicin—breast cancer	3.2e-05	0.000297	CcSEcCtD
Zileuton—Nausea—Methotrexate—breast cancer	3.2e-05	0.000296	CcSEcCtD
Zileuton—Diarrhoea—Doxorubicin—breast cancer	3.19e-05	0.000295	CcSEcCtD
Zileuton—Rash—Epirubicin—breast cancer	3.17e-05	0.000294	CcSEcCtD
Zileuton—Dermatitis—Epirubicin—breast cancer	3.17e-05	0.000294	CcSEcCtD
Zileuton—Headache—Epirubicin—breast cancer	3.15e-05	0.000292	CcSEcCtD
Zileuton—Dizziness—Doxorubicin—breast cancer	3.08e-05	0.000285	CcSEcCtD
Zileuton—Nausea—Epirubicin—breast cancer	2.99e-05	0.000277	CcSEcCtD
Zileuton—Vomiting—Doxorubicin—breast cancer	2.96e-05	0.000274	CcSEcCtD
Zileuton—Rash—Doxorubicin—breast cancer	2.94e-05	0.000272	CcSEcCtD
Zileuton—Dermatitis—Doxorubicin—breast cancer	2.93e-05	0.000272	CcSEcCtD
Zileuton—Headache—Doxorubicin—breast cancer	2.92e-05	0.00027	CcSEcCtD
Zileuton—Nausea—Doxorubicin—breast cancer	2.77e-05	0.000256	CcSEcCtD
Zileuton—PTGS1—Metabolism—HMOX1—breast cancer	4.54e-06	4.93e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—ITPR1—breast cancer	4.53e-06	4.92e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—ABCC1—breast cancer	4.53e-06	4.91e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—GSTA3—breast cancer	4.53e-06	4.91e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—HMMR—breast cancer	4.53e-06	4.91e-05	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—IL6—breast cancer	4.51e-06	4.89e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—NAT2—breast cancer	4.5e-06	4.89e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PPARGC1B—breast cancer	4.38e-06	4.76e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—ABCB1—breast cancer	4.36e-06	4.73e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ESRRA—breast cancer	4.33e-06	4.7e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ANGPTL4—breast cancer	4.33e-06	4.7e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—TYMS—breast cancer	4.28e-06	4.64e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	4.27e-06	4.63e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	4.27e-06	4.63e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—GSTM1—breast cancer	4.23e-06	4.59e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—NCOR1—breast cancer	4.23e-06	4.59e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PLA2G4A—breast cancer	4.23e-06	4.59e-05	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—CAV1—breast cancer	4.23e-06	4.59e-05	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—AKT1—breast cancer	4.16e-06	4.51e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—CA9—breast cancer	4.14e-06	4.49e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—GSTA4—breast cancer	4.14e-06	4.49e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—GPI—breast cancer	4.11e-06	4.46e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—HADHB—breast cancer	4.11e-06	4.46e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—breast cancer	4.09e-06	4.43e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—breast cancer	4.07e-06	4.42e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—GPX1—breast cancer	4.05e-06	4.4e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	4.05e-06	4.39e-05	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	4.04e-06	4.39e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—GPX2—breast cancer	4.03e-06	4.38e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—GSTA2—breast cancer	4.03e-06	4.38e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—CYP1A1—breast cancer	4.01e-06	4.35e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—GPX4—breast cancer	3.99e-06	4.32e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—SULT1A1—breast cancer	3.99e-06	4.32e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—ERCC2—breast cancer	3.98e-06	4.32e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—MED12—breast cancer	3.95e-06	4.28e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—DPYD—breast cancer	3.95e-06	4.28e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ALDH7A1—breast cancer	3.92e-06	4.25e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ALDH1A1—breast cancer	3.92e-06	4.25e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—IDH1—breast cancer	3.89e-06	4.22e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—GSTA1—breast cancer	3.89e-06	4.22e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—ALDOA—breast cancer	3.89e-06	4.22e-05	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PIK3CG—breast cancer	3.85e-06	4.18e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—NAT2—breast cancer	3.85e-06	4.18e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—NCOA3—breast cancer	3.77e-06	4.09e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—NME1—breast cancer	3.76e-06	4.08e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PHGDH—breast cancer	3.76e-06	4.08e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—FHL2—breast cancer	3.76e-06	4.08e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ADSL—breast cancer	3.76e-06	4.08e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—UMPS—breast cancer	3.76e-06	4.08e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—SLC2A2—breast cancer	3.75e-06	4.07e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—MTHFR—breast cancer	3.74e-06	4.06e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	3.71e-06	4.02e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—LDHB—breast cancer	3.69e-06	4e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—HPSE—breast cancer	3.69e-06	4e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—BRIP1—breast cancer	3.69e-06	4e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—CPT1A—breast cancer	3.67e-06	3.98e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—MTR—breast cancer	3.67e-06	3.98e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—ABCG2—breast cancer	3.67e-06	3.98e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—HPGDS—breast cancer	3.6e-06	3.91e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—HBA1—breast cancer	3.58e-06	3.88e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—GSTA3—breast cancer	3.49e-06	3.79e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—HMMR—breast cancer	3.49e-06	3.79e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ABCC1—breast cancer	3.49e-06	3.79e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—ACHE—breast cancer	3.49e-06	3.79e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—GSTT1—breast cancer	3.49e-06	3.79e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—breast cancer	3.48e-06	3.77e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—CAV1—breast cancer	3.45e-06	3.74e-05	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PIK3CD—breast cancer	3.39e-06	3.68e-05	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—PIK3CA—breast cancer	3.38e-06	3.67e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PPARGC1B—breast cancer	3.38e-06	3.67e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—MED12—breast cancer	3.37e-06	3.66e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—DPYD—breast cancer	3.37e-06	3.66e-05	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—ALB—breast cancer	3.34e-06	3.63e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—ALDOA—breast cancer	3.32e-06	3.6e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—CYP17A1—breast cancer	3.31e-06	3.59e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	3.3e-06	3.58e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PTGS1—breast cancer	3.27e-06	3.55e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—ENO1—breast cancer	3.27e-06	3.55e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	3.26e-06	3.54e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—NCOA3—breast cancer	3.23e-06	3.5e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—ALB—breast cancer	3.22e-06	3.49e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—CYP2D6—breast cancer	3.21e-06	3.48e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—SLC2A2—breast cancer	3.2e-06	3.47e-05	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—NOS3—breast cancer	3.2e-06	3.47e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—GSTA4—breast cancer	3.2e-06	3.47e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—CA9—breast cancer	3.2e-06	3.47e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	3.17e-06	3.44e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—NCOA2—breast cancer	3.15e-06	3.42e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PIK3CG—breast cancer	3.14e-06	3.41e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—ABCG2—breast cancer	3.14e-06	3.4e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—CPT1A—breast cancer	3.14e-06	3.4e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—MTR—breast cancer	3.14e-06	3.4e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—GSTA2—breast cancer	3.11e-06	3.38e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—GPX2—breast cancer	3.11e-06	3.38e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—HPGDS—breast cancer	3.08e-06	3.34e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—SULT1A1—breast cancer	3.08e-06	3.34e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—GPX4—breast cancer	3.08e-06	3.34e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—HBA1—breast cancer	3.06e-06	3.32e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—FASN—breast cancer	3.06e-06	3.31e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—BCHE—breast cancer	3.04e-06	3.3e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—SLC5A5—breast cancer	3.01e-06	3.26e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—IDH1—breast cancer	3e-06	3.26e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—GSTA1—breast cancer	3e-06	3.26e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—GSTT1—breast cancer	2.98e-06	3.24e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—ACHE—breast cancer	2.98e-06	3.24e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—NAT2—breast cancer	2.97e-06	3.22e-05	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PIK3CB—breast cancer	2.95e-06	3.2e-05	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PTGS2—breast cancer	2.93e-06	3.17e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—NQO1—breast cancer	2.9e-06	3.15e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—SLC2A1—breast cancer	2.9e-06	3.15e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	2.84e-06	3.08e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—CYP3A4—breast cancer	2.83e-06	3.07e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—CYP17A1—breast cancer	2.82e-06	3.06e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	2.82e-06	3.06e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—ENO1—breast cancer	2.8e-06	3.03e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PTGS1—breast cancer	2.8e-06	3.03e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	2.79e-06	3.02e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—CYP1B1—breast cancer	2.78e-06	3.02e-05	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—AKT1—breast cancer	2.76e-06	3e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PIK3CD—breast cancer	2.76e-06	3e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	2.75e-06	2.98e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—CYP2D6—breast cancer	2.74e-06	2.98e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—HSP90AA1—breast cancer	2.73e-06	2.96e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—ALB—breast cancer	2.73e-06	2.96e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—NCOA2—breast cancer	2.69e-06	2.92e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—NCOA1—breast cancer	2.65e-06	2.88e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—CYP19A1—breast cancer	2.62e-06	2.84e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—STK11—breast cancer	2.62e-06	2.84e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—FASN—breast cancer	2.61e-06	2.83e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—NOS3—breast cancer	2.61e-06	2.83e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—MED12—breast cancer	2.6e-06	2.83e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—DPYD—breast cancer	2.6e-06	2.83e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—BCHE—breast cancer	2.6e-06	2.82e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—SLC5A5—breast cancer	2.57e-06	2.79e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ALDOA—breast cancer	2.56e-06	2.78e-05	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PTEN—breast cancer	2.55e-06	2.77e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—NCOA3—breast cancer	2.49e-06	2.7e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—NQO1—breast cancer	2.48e-06	2.69e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—SLC2A1—breast cancer	2.48e-06	2.69e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—SLC2A2—breast cancer	2.47e-06	2.68e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.46e-06	2.66e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—COMT—breast cancer	2.43e-06	2.64e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	2.43e-06	2.63e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—MTR—breast cancer	2.42e-06	2.63e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ABCG2—breast cancer	2.42e-06	2.63e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—CPT1A—breast cancer	2.42e-06	2.63e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—GSTP1—breast cancer	2.42e-06	2.63e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—CYP3A4—breast cancer	2.42e-06	2.62e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PIK3CB—breast cancer	2.41e-06	2.61e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	2.41e-06	2.61e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—HMOX1—breast cancer	2.39e-06	2.59e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PTGS2—breast cancer	2.39e-06	2.59e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—ITPR1—breast cancer	2.38e-06	2.58e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—CYP1B1—breast cancer	2.38e-06	2.58e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—HPGDS—breast cancer	2.37e-06	2.58e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—HBA1—breast cancer	2.36e-06	2.56e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—HSP90AA1—breast cancer	2.33e-06	2.53e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—GSTT1—breast cancer	2.3e-06	2.5e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ACHE—breast cancer	2.3e-06	2.5e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—ABCB1—breast cancer	2.29e-06	2.49e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—NCOA1—breast cancer	2.27e-06	2.46e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—TYMS—breast cancer	2.25e-06	2.44e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—STK11—breast cancer	2.24e-06	2.43e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—CYP19A1—breast cancer	2.24e-06	2.43e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—GSTM1—breast cancer	2.22e-06	2.41e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—NCOR1—breast cancer	2.22e-06	2.41e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PLA2G4A—breast cancer	2.22e-06	2.41e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—CYP17A1—breast cancer	2.18e-06	2.37e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PTGS1—breast cancer	2.16e-06	2.34e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ENO1—breast cancer	2.16e-06	2.34e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—GPX1—breast cancer	2.13e-06	2.31e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—CYP2D6—breast cancer	2.12e-06	2.3e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—CYP1A1—breast cancer	2.11e-06	2.29e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.1e-06	2.28e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—ERCC2—breast cancer	2.09e-06	2.27e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PTEN—breast cancer	2.08e-06	2.26e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—COMT—breast cancer	2.08e-06	2.25e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—NCOA2—breast cancer	2.08e-06	2.25e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—GSTP1—breast cancer	2.07e-06	2.24e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—HMOX1—breast cancer	2.04e-06	2.21e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—ITPR1—breast cancer	2.04e-06	2.21e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—FASN—breast cancer	2.01e-06	2.19e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—BCHE—breast cancer	2.01e-06	2.18e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—SLC5A5—breast cancer	1.98e-06	2.15e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—MTHFR—breast cancer	1.97e-06	2.13e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—ABCB1—breast cancer	1.96e-06	2.12e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—TYMS—breast cancer	1.92e-06	2.09e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—SLC2A1—breast cancer	1.91e-06	2.08e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—NQO1—breast cancer	1.91e-06	2.08e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—GSTM1—breast cancer	1.9e-06	2.06e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PLA2G4A—breast cancer	1.9e-06	2.06e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—NCOR1—breast cancer	1.9e-06	2.06e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—CYP1B1—breast cancer	1.84e-06	1.99e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—GPX1—breast cancer	1.82e-06	1.97e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—CAV1—breast cancer	1.81e-06	1.97e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—CYP1A1—breast cancer	1.8e-06	1.96e-05	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PIK3CA—breast cancer	1.8e-06	1.95e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—HSP90AA1—breast cancer	1.8e-06	1.95e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—ERCC2—breast cancer	1.79e-06	1.94e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—NCOA1—breast cancer	1.75e-06	1.9e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.73e-06	1.88e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—CYP19A1—breast cancer	1.73e-06	1.87e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—STK11—breast cancer	1.73e-06	1.87e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—MTHFR—breast cancer	1.68e-06	1.82e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PIK3CG—breast cancer	1.65e-06	1.79e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—COMT—breast cancer	1.6e-06	1.74e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—GSTP1—breast cancer	1.6e-06	1.73e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—HMOX1—breast cancer	1.57e-06	1.71e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ITPR1—breast cancer	1.57e-06	1.7e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—CAV1—breast cancer	1.55e-06	1.68e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ABCB1—breast cancer	1.51e-06	1.64e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—TYMS—breast cancer	1.48e-06	1.61e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.48e-06	1.61e-05	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—AKT1—breast cancer	1.47e-06	1.6e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PIK3CA—breast cancer	1.47e-06	1.59e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.47e-06	1.59e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—NCOR1—breast cancer	1.47e-06	1.59e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—GSTM1—breast cancer	1.47e-06	1.59e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PIK3CD—breast cancer	1.45e-06	1.58e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—ALB—breast cancer	1.43e-06	1.56e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PIK3CG—breast cancer	1.41e-06	1.53e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—GPX1—breast cancer	1.4e-06	1.52e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—CYP1A1—breast cancer	1.39e-06	1.51e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ERCC2—breast cancer	1.38e-06	1.5e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—NOS3—breast cancer	1.37e-06	1.49e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—MTHFR—breast cancer	1.3e-06	1.41e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PIK3CB—breast cancer	1.27e-06	1.37e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PTGS2—breast cancer	1.25e-06	1.36e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PIK3CD—breast cancer	1.24e-06	1.35e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—ALB—breast cancer	1.22e-06	1.33e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—AKT1—breast cancer	1.2e-06	1.3e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—CAV1—breast cancer	1.2e-06	1.3e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—NOS3—breast cancer	1.17e-06	1.27e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PTEN—breast cancer	1.09e-06	1.19e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PIK3CG—breast cancer	1.09e-06	1.18e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PIK3CB—breast cancer	1.08e-06	1.17e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PTGS2—breast cancer	1.07e-06	1.16e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PIK3CD—breast cancer	9.58e-07	1.04e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ALB—breast cancer	9.45e-07	1.03e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PTEN—breast cancer	9.35e-07	1.01e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—NOS3—breast cancer	9.04e-07	9.81e-06	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PIK3CB—breast cancer	8.35e-07	9.06e-06	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PTGS2—breast cancer	8.27e-07	8.97e-06	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PIK3CA—breast cancer	7.72e-07	8.37e-06	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PTEN—breast cancer	7.21e-07	7.83e-06	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PIK3CA—breast cancer	6.59e-07	7.15e-06	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—AKT1—breast cancer	6.3e-07	6.84e-06	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—AKT1—breast cancer	5.39e-07	5.84e-06	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PIK3CA—breast cancer	5.09e-07	5.52e-06	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—AKT1—breast cancer	4.16e-07	4.51e-06	CbGpPWpGaD
